Oncology Cost Control

Cancer treatments and specialty pharmacy drive huge costs today. Together, these categories represent between 10% and 20% of plan/sponsor medical expenses. Both have costs that are growing at rates unsustainably higher than the rest of the medical spend. What is more, new treatments are introduced almost daily it seems. And the price tags are staggering. But most challenging is that cancer and specialty pharmacy have integral ties to physician reimbursement and compensation and both require specialized knowledge to manage effectively.

Intellogy Health Designs is focused on helping health plans address their oncology and specialty pharmacy programs. We bring specialized resources to focus on creating solutions that meet the unique market, provider and member needs facing health plans today.

Our Oncology Cost Control service helps payers identify and prioritize opportunities in the following areas:

• Evidence-based treatment programs to limit unwarranted variation
• Provider network development and management
• Screening programs to promote prevention and early detection
• New technologies planning to manage technology introductions, unit costs and utilization
• Side effect management to limit inappropriate ER visits and hospitalizations
• Centers of excellence to facilitate multidisciplinary care
• Treatment planning to promote consideration of hospice use
• Survivorship support to facilitate recurrence identification and management